The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport
Abstract
Increased blood cholesterol is an independent risk factor for atherosclerotic cardiovascular disease. Cholesterol homeostasis in the body is controlled mainly by endogenous synthesis, intestinal absorption, and hepatic excretion. Niemann-Pick C1-Like 1 (NPC1L1) is a polytopic transmembrane protein localized at the apical membrane of enterocytes and the canalicular membrane of hepatocytes. It functions as a sterol transporter to mediate intestinal cholesterol absorption and counterbalances hepatobiliary cholesterol excretion. NPC1L1 is the molecular target of ezetimibe, a potent cholesterol absorption inhibitor that is widely used in treating hypercholesterolemia. Recent findings suggest that NPC1L1 deficiency or ezetimibe treatment also prevents diet-induced hepatic steatosis and obesity in addition to reducing blood cholesterol. Future studies should focus on molecular mechanisms underlying NPC1L1-dependent cholesterol transport and elucidation of how a cholesterol transporter modulates the pathogenesis of metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Statins and NPC1L1 inhibitors enhance LDLR expression in hepatocytes, thereby promoting serum LDL-C clearance.
“Besides PCSK9 antibodies, current clinical therapies including statins13,14 and NPC1L1 (NPC1 like intracellular cholesterol transporter 1) inhibitors15enhance LDLR expression in hepatocytes, thereby promoting serum LDL-C clearance.”
From ABCC4 impairs the clearance of plasma LDL cholesterol through suppressing LDLR expression in the liver (2025) · cites this paper as [15]
The Introduction says ezetimibe inhibits intestinal cholesterol absorption and lowers blood LDL-C. The section on genetic variation in NPC1L1 says increased absorption downregulates hepatic LDL receptors and reduces LDL clearance. These passages support the proposed pathway, but do not directly establish that NPC1L1 inhibitors enhance LDLR expression in hepatocytes or that this increase causes their LDL-C-lowering effect. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
The discovery and development of HMG-CoA reductase inhibitors.
Endo, A. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41379-3 · Cited by 847
Flagged first, then by citations
Research works printed but not linked: 147
- 10.1172/JCI104090 · DOI
- 10.1172/JCI104909 · DOI
- 10.1146/annurev.physiol.69.031905.160725 · DOI
- 10.1053/j.gastro.2007.06.019 · DOI
- 10.1210/jc.87.2.423 · DOI
- 10.1161/circ.106.25.3143 · DOI · Paper page
- 10.1021/jm970701f · DOI
- 10.1161/hq1201.100260 · DOI · Paper page
- 10.1038/sj.bjp.0703235 · DOI
- 10.1053/meta.2001.26737 · DOI · Paper page
- 10.1016/S0002-9149(02)02774-1 · DOI
- 10.1016/S0735-1097(02)02610-4 · DOI
- 10.1126/science.1093131 · DOI
- 10.1073/pnas.0500269102 · DOI · Paper page
- 10.1073/pnas.0800936105 · DOI
- 10.1006/geno.2000.6151 · DOI
- 10.1126/science.277.5323.228 · DOI · Paper page
- 10.1126/science.277.5323.232 · DOI
- 10.1074/jbc.M511123200 · DOI
- 10.1124/jpet.106.114181 · DOI
- 10.1016/j.bbagen.2004.12.021 · DOI
- 10.1126/science.290.5500.2295 · DOI
- 10.1194/jlr.M800669-JLR200 · DOI
- 10.1016/S0168-9525(02)02640-9 · DOI
- 10.1016/j.molcel.2004.06.019 · DOI · Paper page
- 10.1073/pnas.0405255101 · DOI
- 10.1074/jbc.M409110200 · DOI
- 10.1172/JCI30060 · DOI
- 10.1194/jlr.M300042-JLR200 · DOI
- 10.1126/science.289.5484.1524 · DOI
- McNamara DJ, 1980, J. Lipid Res., 21, 1058, 10.1016/S0022-2275(20)34766-0 · DOI
- Umeda Y, 2001, J. Lipid Res., 42, 1214, 10.1016/S0022-2275(20)31571-6 · DOI
- 10.1016/0021-9150(94)05474-W · DOI
- 10.1074/jbc.M301311200 · DOI
- 10.1073/pnas.091021198 · DOI
- 10.1194/jlr.M400400-JLR200 · DOI
- 10.1194/jlr.M600325-JLR200 · DOI
- 10.1194/jlr.M700345-JLR200 · DOI
- 10.1016/j.bbrc.2005.12.137 · DOI
- 10.1053/j.gastro.2004.10.006 · DOI
- 10.1016/S0092-8674(00)80213-5 · DOI · Paper page
- 10.1074/jbc.M405817200 · DOI · Paper page
- 10.1194/jlr.M500232-JLR200 · DOI
- 10.1161/ATVBAHA.107.149914 · DOI
- 10.1002/hep.21380 · DOI
- 10.1194/jlr.M600439-JLR200 · DOI
- 10.1152/ajpgi.00306.2006 · DOI
- 10.1194/jlr.M900274 · DOI
- 10.1007/s11095-007-9496-9 · DOI
- 10.1093/jn/136.8.2135 · DOI
- 10.1016/0361-9230(91)90145-A · DOI
- Wilson MD, 1994, J. Lipid Res., 35, 943, 10.1016/S0022-2275(20)40109-9 · DOI
- 10.1097/00041433-200306000-00002 · DOI
- 10.1146/annurev.nu.03.070183.000443 · DOI
- 10.1126/science.290.5497.1771 · DOI
- 10.1038/87170 · DOI
- 10.1073/pnas.252582399 · DOI
- 10.1172/JCI0216001 · DOI
- 10.1172/JCI27352 · DOI · Paper page
- 10.1161/ATVBAHA.107.160465 · DOI
- 10.1074/jbc.273.41.26747 · DOI
- 10.1074/jbc.272.15.10279 · DOI
- 10.1172/JCI6576 · DOI · Paper page
- 10.1016/S0016-5085(72)80089-1 · DOI
- Bosner MS, 1999, J. Lipid Res., 40, 302, 10.1016/S0022-2275(20)33370-8 · DOI
- 10.1001/archinte.130.4.552 · DOI
- 10.1194/jlr.M200144-JLR200 · DOI
- 10.1194/jlr.M500124-JLR200 · DOI
- 10.1194/jlr.P600009-JLR200 · DOI
- 10.1152/ajpgi.90275.2008 · DOI
- Dietschy JM, 1993, J. Lipid Res., 34, 1637, 10.1016/S0022-2275(20)35728-X · DOI · Paper page
- 10.1074/jbc.M310223200 · DOI
- 10.1186/1471-230X-4-21 · DOI
- 10.1152/ajpgi.90372.2008 · DOI
- 10.1053/j.gastro.2008.03.011 · DOI
- 10.1111/j.1478-3231.2008.01808.x · DOI
- 10.1073/pnas.78.3.1396 · DOI
- 10.1172/JCI113321 · DOI
- 10.1073/pnas.0508483103 · DOI
- 10.1093/hmg/ddn108 · DOI
- 10.1194/jlr.P001172 · DOI
- 10.1186/1476-511X-4-16 · DOI
- 10.1016/j.ygeno.2005.08.007 · DOI
- 10.1111/j.1399-0004.2004.00388.x · DOI
- 10.1111/j.1365-2265.2007.03144.x · DOI
- 10.1016/j.numecd.2009.03.023 · DOI
- 10.1194/jlr.M800439-JLR200 · DOI
- 10.1161/01.ATV.0000257627.40486.46 · DOI
- 10.1042/BJ20070168 · DOI
- 10.1016/j.cmet.2008.04.001 · DOI
- 10.1194/jlr.M800145-JLR200 · DOI
- 10.1124/mol.107.043844 · DOI
- 10.1194/jlr.M600174-JLR200 · DOI
- 10.1016/j.bbalip.2007.03.002 · DOI
- 10.1016/j.bbalip.2007.05.011 · DOI
- 10.1042/BJ20070168 · DOI
- 10.1016/0092-8674(83)90356-2 · DOI
- 10.1074/jbc.M504609200 · DOI
- 10.1146/annurev.biochem.72.121801.161800 · DOI · Paper page
- 10.1038/clpt.2009.209 · DOI
- 10.1016/j.cell.2009.03.049 · DOI · Paper page
- 10.1016/j.febslet.2010.03.030 · DOI
- 10.1074/jbc.M109.034355 · DOI
- 10.1016/S1388-1981(01)00190-1 · DOI
- 10.1073/pnas.0400441101 · DOI
- 10.1074/jbc.M406309200 · DOI
- Mardones P, 2001, J. Lipid Res., 42, 170, 10.1016/S0022-2275(20)31676-X · DOI
- 10.1074/jbc.M504609200 · DOI
- 10.1194/jlr.M900036-JLR200 · DOI
- 10.1016/j.atherosclerosis.2007.10.012 · DOI
- 10.1124/mol.106.027896 · DOI
- 10.1172/JCI106315 · DOI
- 10.1172/JCI107640 · DOI
- Salen G, 1992, J. Lipid Res., 33, 945, 10.1016/S0022-2275(20)41411-7 · DOI
- 10.1161/01.CIR.0000116766.31036.03 · DOI
- 10.1053/j.gastro.2006.02.027 · DOI
- 10.1016/j.jacl.2008.01.008 · DOI
- 10.1194/jlr.M300377-JLR200 · DOI
- 10.1074/jbc.M605603200 · DOI
- 10.1021/bi800292v · DOI
- 10.1056/NEJMoa0800742 · DOI · Paper page
- 10.5551/jat.14.99 · DOI
- 10.1172/JCI22422 · DOI · Paper page
- 10.1097/MOG.0b013e3283294a18 · DOI
- 10.1053/jhep.2003.50325 · DOI
- Clark JM., 2006, J. Clin. Gastroenterol., 40, 5
- 10.1542/peds.2006-1212 · DOI
- 10.1002/hep.20466 · DOI · Paper page
- 10.1002/hep.21763 · DOI · Paper page
- 10.1042/bj0740441 · DOI
- 10.1016/j.ejphar.2008.01.045 · DOI
- 10.1016/j.febslet.2007.11.023 · DOI
- 10.1038/ng0596-18 · DOI · Paper page
- 10.3748/wjg.v12.i27.4369 · DOI
- 10.1016/j.jhep.2009.05.017 · DOI
- 10.1194/jlr.M006353 · DOI
- 10.2337/dc09-1765 · DOI
- 10.1111/j.1872-034X.2010.00644.x · DOI
- 10.1186/1476-511X-9-29 · DOI
- 10.1016/j.cmet.2007.12.009 · DOI
- 10.1152/ajpendo.00343.2009 · DOI
- 10.5551/jat.2378 · DOI
- 10.1016/j.cmet.2007.05.005 · DOI · Paper page
- 10.1038/383728a0 · DOI · Paper page
- 10.1101/gad.850400 · DOI · Paper page
- 10.1194/jlr.M008599 · DOI
- 10.1016/j.clinthera.2004.11.016 · DOI
Cited by
Sorted by citations
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Regulation of intestinal lipid metabolism: current concepts and relevance to disease
Ko, C.-W., Qu, J., Black, D. D., & Tso, P. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0250-7 · Cited by 510
Morrone, D., Weintraub, W. S., Toth, P. P., Hanson, M. E., Lowe, R. S., Lin, J., Shah, A. K., & Tershakovec, A. M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.016 · Cited by 263
Araki, E., Yamashita, S., Arai, H., Yokote, K., Satoh, J., Inoguchi, T., Nakamura, J., Maegawa, H., Yoshioka, N., Tanizawa, Y., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1589 · Cited by 164
Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events
Zhan, S., Tang, M., Liu, F., Xia, P., Shu, M., & Wu, X. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012502.pub2 · Cited by 109
Hypercholesterolemia Induces Angiogenesis and Accelerates Growth of Breast Tumors In Vivo
Pelton, K., Coticchia, C. M., Curatolo, A. S., Schaffner, C. P., Zurakowski, D., Solomon, K. R., & Moses, M. A. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.03.006 · Cited by 109
Niemann-Pick C1-Like 1 (NPC1L1) inhibition and cardiovascular diseases
Pirillo, A., L. Catapano, A., & D. Norata, G. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160229114111 · Cited by 45
The Administration of Probiotics against Hypercholesterolemia: A Systematic Review
Sivamaruthi, B. S., Bharathi, M., Kesika, P., Suganthy, N., & Chaiyasut, C. (2021) · Applied Sciences · doi:10.3390/app11156913 · Cited by 20
Chen, J., Huang, H., Chen, C., Xia, G., Huang, H., Xiong, Y., Luo, P., Chen, Y., Li, J., Wen, L., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08818-x · Cited by 1
Metadata
- Authors
- Jia, L., Betters, J. L., & Yu, L.
- Venue
- Annual Review of Physiology
- Publisher
- Annual Reviews
- Published
- 2011-03-17
- Volume
- 73
- Issue
- 1
- Pages
- 239-259
- ISSN
- 0066-4278
- 1545-1585
- PMC
- PMC3965667
- Cited by
- 356
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review